Duke Lung and Heart-Lung Transplant Program remains at the cutting edge of many innovative and exciting research and clinical therapies.
Our internationally recognized physician-scientists strive to advance lung transplant and improve patient outcomes by conducting pioneering clinical, basic, and translational research aimed at developing new treatment strategies. Their leading-edge work, which frequently appears in peer-reviewed publications, continues to advance this specialty, while giving patients opportunities to participate in innovative clinical trials.
For example, our program has led studies that have identified gastric reflux as a potential cause of pulmonary complications and demonstrated that anti-reflux surgery can help maintain and improve lung function in selected patients.
In addition, our group has led the development of innovative strategies to prevent cytomegalovirus, a common infection that occurs after lung transplantation and is associated with impaired lung function.
Duke is also involved in research to: